Overview Inhaled Nitric Oxide in Pulmonary Embolism Status: Completed Trial end date: 2009-12-01 Target enrollment: Participant gender: Summary The purpose of the study is to determine if inhaled nitric oxide, a potent and selective pulmonary vasodilator, is beneficial in patients with acute pulmonary embolism causing increased right ventricular afterload. Phase: Phase 2 Details Lead Sponsor: Medical University of ViennaTreatments: Nitric Oxide